 |
 |
 |
|
 |
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA
Updated on December 08, 2008
The Food and Drug Administration (FDA) is requesting nominations for members to serve on its advisory committees. FDA has a special interest in ensuring that women, minority groups, and individuals with disabilities are adequately represented on its advisory committees and, therefore, encourages nominations of qualified candidates from these groups.
Please be aware that:
For more information, please visit:
For more information on how to nominate one or more qualified persons, please go to:
| Committee | Function | Qualifications | Current Vacancies |
|---|---|---|---|
| Allergenic Products Advisory Committee | Reviews and evaluates available data concerning the safety, effectiveness, and adequacy of labeling of marketed and investigational allergenic biological products or materials that are administered to humans for the diagnosis, prevention, or treatment of allergies and allergic disease as well as the affirmation or revocation of biological product licenses, on the safety, effectiveness, and labeling of the products, on clinical and laboratory studies of such products, on amendments or revisions to regulations governing the manufacture, testing and licensing of allergenic biological products, and on the quality and relevance of FDA's research programs. | Knowledgeable in the fields of allergy, immunology, pediatrics, internal medicine, biochemistry, and related specialties. | 3 |
| Blood Products Advisory Committee | Reviews and evaluates available data concerning the safety, effectiveness, and appropriate use of blood products derived from blood and serum or biotechnology which are intended for use in the diagnosis, prevention, or treatment of human diseases as well as the safety, effectiveness, and labeling of the products, on clinical and laboratory studies involving such products, on the affirmation or revocation of biological product licenses, and on the quality and relevance of FDA's research program which provides the scientific support for regulating these products | Knowledgeable in the fields of clinical and administrative medicine, hematology, immunology, blood banking, surgery, internal medicine, biochemistry, engineering, biological and physical sciences, biotechnology, computer technology, statistics, epidemiology, sociology/ethics, and other related professions. | 2 |
| Cellular, Tissue and Gene Therapies Advisory Committee | Reviews and evaluates available data relating to the safety, effectiveness, and appropriate use of human cells, human tissues, gene transfer therapies and xenotransplantation products which are intended for transplantation, implantation, infusion and transfer in the prevention and treatment of a broad spectrum of human diseases and in the reconstruction, repair or replacement of tissues for various conditions, as well as considers the quality and relevance of FDA's research program which provides scientific support for the regulation of these products | Knowledgeable in the fields of cellular therapies, tissue transplantation, gene transfer therapies and xenotransplantation (biostatistics, bioethics, hematology/oncology, human tissues and transplantation, reproductive medicine, general medicine and various medical specialties including surgery and oncology, immunology, virology, molecular biology, cell biology, developmental biology, tumor biology, biochemistry, rDNA technology, nuclear medicine, gene therapy, infectious diseases, and cellular kinetics). | 4 |
| Transmissible Spongiform Encephalopathies Advisory Committee | Reviews and evaluates available scientific data concerning the safety of products which may be at risk for transmission of spongiform encephalopathies having an impact on the public health, as well as considers the quality and relevance of FDA's research program which provides scientific support for the regulation of these products | Knowledgeable in the fields of clinical and administrative medicine, hematology, virology, neurovirology, neurology, infectious diseases, immunology, transfusion medicine, surgery, internal medicine, biochemistry, biostatistics, epidemiology, biological and physical sciences, sociology/ethics, and other related professions. | 1 |
| Vaccines and Related Biological Products Advisory Committee | Reviews and evaluates data concerning the safety, effectiveness, and appropriate use of vaccines and related biological products which are intended for use in the prevention, treatment, or diagnosis of human diseases, as well as considers the quality and relevance of FDA's research program which provides scientific support for the regulation of these products. | Knowledgeable in the fields of immunology, molecular biology, rDNA, virology, bacteriology, epidemiology or biostatistics, allergy, preventive medicine, infectious diseases, pediatrics, microbiology, and biochemistry. | 4 |
| Committee | Function | Qualifications | Current Vacancies |
|---|---|---|---|
| Anesthetic and Life Support Drugs Advisory Committee | Reviews and evaluates available data concerning the safety and effectiveness of marketed and investigational human drug products for use in anesthesiology and surgery. | Knowledgeable in the fields of anesthesiology, surgery, epidemiology or statistics, and related specialties. | 3 |
| Anti-Infective Drugs Advisory Committee | Reviews and evaluates available data concerning the safety and effectiveness of marketed and investigational human drug products for use in the treatment of infectious diseases and disorders. | Knowledgeable in the fields of infectious disease, internal medicine, microbiology, pediatrics, epidemiology or statistics, and related specialties. | 0 |
| Antiviral Drugs Advisory Committee | Reviews and evaluates available data concerning the safety and effectiveness of marketed and investigational human drug products for use in the treatment of acquired immune deficiency syndrome, human immunodeficiency virus related illnesses, and other viral, fungal and mycobacterial infections. | Knowledgeable in the fields of clinical pharmacology, internal medicine, infectious diseases, microbiology, virology, psychiatry, statistics, epidemiology, ophthalmology, immunology, pediatrics, hematology, and related specialties. | 0 |
| Arthritis Drugs Advisory Committee | Reviews and evaluates data concerning the safety and effectiveness of marketed and investigational human drug products for use in the treatment of arthritis, rheumatism, and related diseases. | Knowledgeable in the fields of arthritis, rheumatology, orthopedics, epidemiology or statistics, analgesics, and related specialties. | 4 |
| Cardiovascular and Renal Drugs Advisory Committee | Reviews and evaluates available data concerning the safety and effectiveness of marketed and investigational human drug products for use in the treatment of cardiovascular and renal disorders. | Knowledgeable in the fields of cardiology, hypertension, arrhythmia, angina, congestive heart failure, diuresis, and biostatistics. | 4 |
| Dermatologic and Ophthalmic Drugs Advisory Committee | Reviews and evaluates available data concerning the safety and effectiveness of marketed and investigational human drug products for use in the treatment of dermatologic and ophthalmic disorders. | Knowledgeable in the fields of dermatology, ophthalmology, internal medicine, pathology, immunology, epidemiology or statistics, and other related professions. | 13 |
| Drug Safety and Risk Management Advisory Committee | Risk management, risk communication, and quantitative evaluation of spontaneous reports for drugs for human use and for any other product for which the FDA has regulatory responsibility. Scientific and medical evaluation of all information gathered by the DHHS and the Department of Justice with regard to safety, efficacy, and abuse potential of drugs or other substances, and recommends actions to be taken by the DHHS with regard to the marketing, investigation, and control of such drugs or other substances. | Knowledgeable in risk communication, risk management, drug safety, medical, behavioral, and biological sciences as they apply to risk management, and drug abuse. | 6 |
| Endocrinologic and Metabolic Drugs Advisory Committee | Reviews and evaluates data concerning the safety and effectiveness of marketed and investigational human drug products for use in the treatment of endocrine and metabolic disorders. | Knowledgeable in the fields of endocrinology, metabolism, epidemiology or statistics, and related specialties. | 2 |
| Gastrointestinal Drugs Advisory Committee | Reviews and evaluates available data concerning the safety and effectiveness of marketed and investigational human drug products for use in the treatment of gastrointestinal diseases. | Knowledgeable in the fields of gastroenterology, endocrinology, surgery, clinical pharmacology, physiology, pathology, liver function, motility, esophagitis, and statistics. | 6 |
| Nonprescription Drugs Advisory Committee | Review and evaluate available data concerning the safety and effectiveness of over-the-counter (nonprescription) human drug products, or any other FDA-regulated product, for use in the treatment of a broad spectrum of human symptoms and diseases and advise the Commissioner either on the promulgation of monographs establishing conditions under which these drugs are generally recognized as safe and effective and not misbranded or on the approval of new drug applications for such drugs. The Committee will serve as a forum for the exchange of views regarding the prescription and nonprescription status, including switches from one status to another, of these various drug products and combinations thereof. The Committee may also conduct peer review of agency sponsored intramural and extramural scientific biomedical programs in support of FDA's mission and regulatory responsibilities. | Knowledgeable in the fields of internal medicine, family practice, clinical toxicology, clinical pharmacology, pharmacy, dentistry, and related specialties. | 11 |
| Oncologic Drugs Advisory Committee | Reviews and evaluates data concerning the safety and effectiveness of marketed and investigational human drug products for use in the treatment of cancer. | Knowledgeable in the fields of general oncology, pediatric oncology, hematologic oncology, immunologic oncology, biostatistics, and other related professions. | 4 |
| Peripheral and Central Nervous System Drugs | Reviews and evaluates data concerning the safety and effectiveness of marketed and investigational human drug products for use in the treatment of neurologic diseases. | Knowledgeable in the fields of neurology, neuropharmacology, neuropathology, otolaryngology, epidemiology or statistics, and related specialties. | 2 |
| Advisory Committee for Pharmaceutical Science | Provide advice on scientific and technical issues concerning the safety, and effectiveness of human generic drug products for use in the treatment of a broad spectrum of human diseases, and as required, any other product for which the FDA has regulatory responsibility. The committee may also review Agency sponsored intramural and extramural biomedical research programs in support of FDA's generic drug regulatory responsibilities. | Knowledgeable in the fields of pharmaceutical manufacturing, clinical pharmacology, pharmacokinetics, bioavailability and bioequivalence research, the design and evaluation of clinical trials, laboratory analytical techniques, pharmaceutical chemistry, physiochemistry, biochemistry, biostatistics and related biomedical and pharmacological specialties. | 21 |
| Psychopharmacologic Drugs Advisory Committee | Reviews and evaluates data concerning the safety and effectiveness of marketed and investigational human drug products for use in the practice of psychiatry and related fields. | Knowledgeable in the fields of psychopharmacology, psychiatry, epidemiology or statistics, and related specialties. | 4 |
| Pulmonary-Allergy Drugs Advisory Committee | Reviews and evaluates available data concerning the safety and effectiveness of marketed and investigational human drug products for use in the treatment of pulmonary disease and diseases with allergic and/or immunologic mechanisms. | Knowledgeable in the fields of pulmonary medicine, allergy, clinical immunology, and epidemiology or statistics. | 7 |
| Advisory Committee for Reproductive Health Drugs | Reviews and evaluates data on the safety and effectiveness of marketed and investigational human drugs for use in the practice of obstetrics, gynecology, and related specialties. | Knowledgeable in the fields of obstetrics, gynecology, endocrinology, pediatrics, epidemiology or statistics and related specialties. | 4 |
| Committee | Function | Qualifications | Current Vacancies |
|---|---|---|---|
| Device Good Manufacturing Practice Advisory Committee | Reviews regulations proposed for promulgation regarding good manufacturing practices governing the methods used in, and the facilities and controls used for, the manufacture, packing, storage, and installation of devices, and makes recommendations to the Commissioner of Food and Drugs regarding the feasibility and reasonableness of those proposed regulations. The Committee also advised the Commissioner with regard to any petition submitte4d by a manufacturer for an exemption or variance from good manufacturing practice regulations that is referred to the committee. | Experts needed to provide cross-cutting scientific or clinical expertise concerning the particular issue in dispute. | 9 |
| National Mammography Quality Assurance Advisory Committee | Advise the agency on the following development of appropriate quality standards and regulations for mammography facilities; standards and regulations for bodies accrediting mammography facilities under this program; regulations with respect to sanctions; procedures for monitoring compliance with standards; establishing a mechanism to investigate consumer complaints; reporting new developments concerning breast imaging which should be considered in the oversight of mammography facilities. As well as determining whether there exists a shortage of mammography facilities in rural and health professional shortage areas and determining the effects of personnel on access to the services of such facilities in such areas; determining whether there will exist a sufficient number of medical physicists after October 1, 1999; and determining the costs and benefits of compliance with these requirements. | Physician, practitioner, or other health professional whose clinical practice, research specialization, or professional expertise includes a significant focus on mammography. | 4 |
| Technical Electronic Product Radiation Standards Advisory Committee | Reviews and evaluates the technical feasibility, reasonableness, and practicability of performance standards for electronic products to control the emission of radiation from such products, and may recommend electronic product radiation safety standards. | Technically qualified by training and experience in one or more fields of science or engineering applicable to electronic product radiation safety. | 15 |
| Medical Devices Advisory Committee; Consists of 18 Panels | Reviews and evaluates data on the
safety and effectiveness of marketed and investigational devices and makes
recommendations for their regulation. With the exception of the Medical
Devices Dispute Resolution Panel, each panel, according to its specialty
area; advises on the classification or reclassification of devices into
one of three regulatory categories; advises on any possible risks to health
associated with the use of devices; advises on formulation of product development
protocols; reviews premarket approval applications for medical devices;
reviews guidelines and guidance documents; recommends exemption of certain
devices from the application of portions of the Act; advises on the necessity
to ban a device; and responds to requests from the agency to review and
make recommendations on specific issues or problems concerning the safety
and effectiveness of devices. With the exception of the Medical Devices
Dispute Resolution Panel, each panel, according to its specialty area, may
also make appropriate recommendations to the Commissioner of Food and Drugs
on issues relating to the design of clinical studies regarding the safety
and effectiveness of marketed and investigational devices. The Dental Products Panel also functions at times as a dental drug panel. The functions of the dental drug panel are to evaluate and recommend whether various prescription drug products should be changed to over-the-counter status and to evaluate data and make recommendations concerning the approval of new dental drug products for human use. The Medical Devices Dispute Resolution Panel provides advice to the Commissioner on complex or contested scientific issues between the FDA and medical device sponsors, applicants, or manufacturers relating to specific products, marketing applications, regulatory decisions and actions by FDA, and Agency guidance and policies. The Panel makes recommendations on issues that are lacking resolution, are highly complex in nature, or result from challenges to regular advisory panel proceedings or Agency decisions or actions. |
Please refer to panels 1- 18 below for specific information regarding desired expertise. | |
| 1. Anesthesiology and Respiratory Therapy Devices Panel of the Medical Devices Advisory Committee | Anesthesiologists, pulmonary medicine specialists, or other experts who have specialized interests in ventilator support, pharmacology, physiology, or the effects and complications of anesthesia. | 0 | |
| 2. Circulatory System Devices Panel of the Medical Devices Advisory Committee | Interventional cardiologists, electrophysiologists, invasive (vascular) radiologists, vascular and cardiothoracic surgeons, and cardiologists with special interest in congestive heart failure. | 3 | |
| 3. Clinical Chemistry and Clinical Toxicology Devices Panel of the Medical Devices Advisory Committee | Doctors of medicine or philosophy with experience in clinical chemistry (e.g., cardiac markers), clinical toxicology, clinical pathology, clinical laboratory medicine, and endocrinology. | 0 | |
| 4. Dental Products Panel of the Medical Devices Advisory Committee | Dentists, engineers and scientists who have expertise in the areas of dental implants, dental materials, periodontology, tissue engineering, and dental anatomy. | 4 | |
| 5. Ear, Nose and Throat Devices Panel of the Medical Devices Advisory Committee | Otologists, neurotologists, audiologists | 5 | |
| 6. Gastroenterology and Urology Devices Panel of the Medical Devices Advisory Committee | Gastroenterologists, urologists and nephrologists | 0 | |
| 7. General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee | Surgeons (general, plastic, reconstructive, pediatric, thoracic, abdominal, pelvic and endoscopic); dermatologists; experts in biomaterials, lasers, wound healing, and quality of life; and biostatisticians. | 2 | |
| 8. General Hospital and Personal Use Devices Panel of the Medical Devices Advisory Committee | Internists, pediatricians, neonatologists, endocrinologists, gerontologists, nurses, biomedical engineers or microbiologists/infection control practitioners or experts. | 0 | |
| 9. Hematology and Pathology Devices Panel of the Medical Devices Advisory Committee | Hematologists (benign and/or malignant hematology), hematopathologists (general and special hematology, coagulation and homeostasis, and hematological oncology), gynecologists with special interests in gynecological oncology, cytopathologists, and molecular pathologists with special interests in development of predictive. | 4 | |
| 10. Immunology Devices Panel of the Medical Devices Advisory Committee | Persons with experience in medical, surgical, or clinical oncology, internal medicine, clinical immunology, allergy, molecular diagnostics, or clinical laboratory medicine. | 3 | |
| 11. Medical Devices Dispute Resolution Panel of the Medical Devices Advisory Committee | Experts with broad, cross-cutting scientific, clinical, analytical or mediation skills. | 4 | |
| 12. Microbiology Devices Panel of the Medical Devices Advisory Committee | Clinicians with an expertise in infectious disease, e.g., pulmonary disease specialists, sexually transmitted disease specialists, pediatric infectious disease specialists, experts in tropical medicine and emerging infectious diseases, mycologists; clinical microbiologists and virologists; clinical virology and microbiology laboratory directors, with expertise in clinical diagnosis and in vitro diagnostic assays, e.g., hepatologists; molecular biologists. | 4 | |
| 13. Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee | Experts in human genetics and in the clinical management of patients with genetic disorders, e.g., pediatricians, obstetricians, neonatologists. The agency is also interested in considering candidates with training in inborn errors of metabolism, biochemical and/or molecular genetics, population genetics, epidemiology and related statistical training. Additionally, individuals with experience in genetic counseling, medical ethics as well as ancillary fields of study will be considered. | 4 | |
| 14. Neurological Devices Panel of the Medical Devices Advisory Committee | Neurosurgeons (cerebrovascular and pediatric), neurologists (stroke, pediatric, pain management, anmovement disorders), interventional neuroradiologists, psychiatrists, and biostatisticians. | 5 | |
| 15. Obstetrics and Gynecology Devices Panel of the Medical Devices Advisory Committee | Experts in perinatology, embryology, reproductive endocrinology, pediatric gynecology, gynecological oncology, operative hysteroscopy, pelviscopy, electrosurgery, laser surgery, assisted reproductive technologies, contraception, postoperative adhesions, and cervical cancer and colposcopy; biostatisticians and engineers with experience in obstetrics/gynecology devices; urogynecologists; experts in breast care; experts in gynecology in the older patient; experts in diagnostic (optical) spectroscopy; experts in midwifery; labor and delivery nursing. | 3 | |
| 16. Ophthalmic Devices Panel of the Medical Devices Advisory Committee | Ophthalmologists with expertise in corneal-external disease, vitreo-retinal surgery, glaucoma, ocular immunology, ocular pathology; optometrists; vision scientists; and ophthalmic professionals with expertise in clinical trial design, quality of life assessment, electrophysiology, low vision rehabilitation, and biostatistics. | 3 | |
| 17. Orthopaedic and Rehabilitation Devices Panel of the Medical Devices Advisory Committee | Orthopedic surgeons (joint spine, trauma, and pediatric); rheumatologists; engineers (biomedical, biomaterials, and biomechanical); experts in rehabilitation medicine, sports medicine, and connective tissue engineering; and biostatisticians. | 5 | |
| 18. Radiological Devices Panel of the Medical Devices Advisory Committee | Physicians with experience in general radiology, mammography, ultrasound, magnetic resonance, computed tomography, other radiological subspecialties and radiation oncology; scientists with experience in diagnostic devices, radiation physics, statistical analysis, digital imaging and image analysis. | 0 |
| Committee | Function | Qualifications | Current Vacancies |
|---|---|---|---|
| Food Advisory Committee | Make recommendations on emerging food safety, food science, nutrition, and other food-related health issues that the FDA considers of primary importance for its food and cosmetics programs. Reviewing and evaluating available data and making recommendations on matters such as those relating to: (1) broad scientific and technical food or cosmetic related issues; (2) the safety of new foods and food ingredients; (3) labeling of foods and cosmetics; (4) nutrient needs and nutritional adequacy; and (5) safe exposure limits for food contaminants. The Committee may also be asked to provide advice and make recommendations on ways of communicating to the public the potential risks associated with these issues and on approaches that might be considered for addressing the issues. | Knowledgeable in the fields of physical sciences, biological and life sciences, food science, risk assessment, nutrition, food technology, molecular biology, and other relevant scientific and technical disciplines. | 2 |
| Committee | Function | Qualifications | Current Vacancies |
|---|---|---|---|
| Veterinary Medicine Advisory Committee | Reviews and evaluates available data concerning the safety and effectiveness of marketed and investigational new animal drugs, feeds, and devices for use in the treatment and prevention of animal diseases and increased animal production. | Knowledgeable in the fields of companion animal medicine, food animal medicine, avian medicine, microbiology, biometrics, toxicology, pathology, pharmacology, animal science, chemistry, public health/epidemiology and minor species/minor use veterinary medicine. | 14 |
| Committee | Function | Qualifications | Current Vacancies |
|---|---|---|---|
| Science Advisory Board to the National Center for Toxicological Research | Reviews and advises the agency on the establishment, implementation and evaluation of the research programs and regulatory responsibilities as it relates to NCTR. The Board will also provide an extra-agency review in ensuring that the research programs at NCTR are scientifically sound and pertinent. | Knowledgeable in the fields related to toxicological research. | 1 |